J&J Wins FDA Nod for Erleada, the First Drug for Nonmetastatic Prostate Cancer Post author:Sam Post published:February 14, 2018 Post category:BioPharma Janssen got a little love from the FDA on Wednesday. Source: BioSpace You Might Also Like CytoSorbents Launches VetResQ For U.S. Veterinary Market January 19, 2017 What You Need to Know About Fortis Therapeutics January 22, 2018 Amgen CEO Tells the Company Plans to Hire 1,600 Employees This Year January 31, 2017
